GDF15 and liver disorder: The nonsteroidal anti-inflammatory drug (NSAID)-activated gene-1 (NAG-1), originally identified for its anticancer and anti-inflammatory properties [1], NAG-1 or GDF15 is now recognized as a multifunctional protein involved in various physiological processes such as obesity, aging, and liver diseases.